Persönlicher Status und Werkzeuge



03.11.2017 Pharmacoproteomic characterisation of human colon and rectal cancer

Most molecular cancer therapies act on protein targets but data on the proteome status of patients and cellular models for proteome‐guided pre‐clinical drug sensitivity studies are only beginning to emerge. Here, we profiled the...[more]

02.11.2017 ProteomicsDB highlighted in Nucleic Acids Research

ProteomicsDB is a protein-centric in-memory database for the exploration of large collections of quantitative mass spectrometry-based proteomics data and is highlighted in the database issue of Nucleic Acids Research.[more]

16.10.2017 Target and identify: triazene linker helps identify azidation sites of labelled proteins

A Triazene linker helps identify azidation sites of labelled proteins via click and cleave strategy. A method for identifying probe modification of proteins via tandem mass spectrometry was developed.[more]

05.09.2017 PROCAL: A set of 40 synthetic peptide standards for proteomics

Here, we describe PROCAL (ProteomeTools Calibration Standard), a set of 40 synthetic peptides standards for retention time indexing, column performance monitoring and collision energy calibration.[more]

02.08.2017 Trimodal mixed mode chromatography enables efficient offline 2D peptide fractionation for proteome analysis

Here, we report an alternative first-dimension separation technique using a commercial trimodal phase incorporating polar embedded reversed phase, weak anion exchange and strong cation exchange material.[more]

10.04.2017 Three awards at Proteomic Forum 2017

We are pleased to announce that members of the chair have been awarded at the Annual meeting of the German Society for Proteome Research (DGMS) in Potsdam.[more]

16.02.2017 Lapatinib resistance in breast cancer cells is accompanied by phosphorylation-mediated reprogramming of glycolysis

We employed explorative mass spectrometry to profile proteome, kinome, and phosphoproteome changes in an established model of lapatinib resistance to systematically investigate initial inhibitor response and subsequent...[more]

Displaying 1 to 7 of 36
<< First < Previous 1-7 8-14 15-21 22-28 29-35 36-36 Next > Last >>